DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell‐rich histological mimics

Central giant cell granulomas of the jaws stromal cells harbour mutations and have osteogenic differentiation capacity, in vivo and in vitro

(2022) Lucyene Miguita et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Sarcoma classification by DNA methylation profiling

(2021) Christian Koelsche et al.   Nature Communications

DNA Methylation Profiling Discriminates between Malignant Pleural Mesothelioma and Neoplastic or Reactive Histologic Mimics

(2021) Luca Bertero et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘ DKFZ Sarcoma Classifier’

(2021) Iben Lyskjær et al.   Journal of Pathology Clinical Research

Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?

(2021) Willem H. Schreuder et al.   BONE

DNA methylation-based classification of malformations of cortical development in the human brain

(2021) Samir Jabari et al.   ACTA NEUROPATHOLOGICA

Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations

(2021) Philipp Jurmeister et al.   JOURNAL OF PATHOLOGY

Invited Review: DNA methylation‐based classification of paediatric brain tumours

(2020) E. Perez et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Cherubism: a systematic literature review of clinical and molecular aspects

(2020) B.R. Chrcanovic et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Drivers underpinning the malignant transformation of giant cell tumour of bone

(2020) Matthew W Fittall et al.   JOURNAL OF PATHOLOGY

H3.3G34W promotes growth and impedes differentiation of osteoblast-like mesenchymal progenitors in Giant Cell Tumour of Bone

(2020) Sima Khazaei et al.   Cancer Discovery

MAPK pathway-activating mutations drive giant cell lesions of the jaws and non-ossifying fibromas of bone

(2019) Carolina Cavalieri Gomes et al.   JOURNAL OF PATHOLOGY

Non‐ossifying fibroma: A RAS‐MAPK driven benign bone neoplasm

(2019) Judith VMG Bovée et al.   JOURNAL OF PATHOLOGY

The diverse roles of DNA methylation in mammalian development and disease

(2019) Maxim V. C. Greenberg et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Making sense of giant cell lesions of the jaws (GCLJ): lessons learned from next‐generation sequencing

(2019) Carolina C Gomes et al.   JOURNAL OF PATHOLOGY

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Activating mutations in the MAP‐kinase pathway define non‐ossifying fibroma of bone

(2018) Daniel Baumhoer et al.   JOURNAL OF PATHOLOGY

TRPV4 and KRAS and FGFR1 gain-of-function mutations drive giant cell lesions of the jaw

(2018) Carolina Cavalieri Gomes et al.   Nature Communications

Epigenetic Determinants of Cancer

(2016) Stephen B. Baylin et al.   Cold Spring Harbor Perspectives in Biology

missMethyl: an R package for analyzing data from Illumina’s HumanMethylation450 platform

(2015) Belinda Phipson et al.   BIOINFORMATICS

DNA methyltransferase 3a regulates osteoclast differentiation by coupling to an S-adenosylmethionine–producing metabolic pathway

(2015) Keizo Nishikawa et al.   NATURE MEDICINE

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

The highly prevalent H3F3A mutation in giant cell tumours of bone is not shared by sporadic central giant cell lesion of the jaws

(2014) Carolina Cavaliéri Gomes et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone

(2013) Sam Behjati et al.   NATURE GENETICS

Epigenetic Regulation during Fetal Femur Development: DNA Methylation Matters

(2013) María C. de Andrés et al.   PLoS One

Cloning and characterization of the human SH3BP2 promoter

(2012) Chun Fan et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

DNA Methylation and Its Basic Function

(2012) Lisa D Moore et al.   NEUROPSYCHOPHARMACOLOGY

Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism

(2011) Noam Levaot et al.   CELL

Structural Basis and Sequence Rules for Substrate Recognition by Tankyrase Explain the Basis for Cherubism Disease

(2011) Sebastian Guettler et al.   CELL